All Outputs (225)

Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review (2010)
Journal Article
Johnson, M. J., Oxberry, S. G., Cleland, J. G., & Clark, A. L. (2010). Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. European journal of heart failure, 12(2), 137-147. https://doi.org/10.1093/eurjhf/hfp194

AIMS: Chronic breathlessness is a major symptom for patients with compensated chronic heart failure (CHF) and its impact is different to the breathlessness resulting from pulmonary oedema. This systematic review aims to establish which tools have bee... Read More about Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review.

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review. (2009)
Journal Article
Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review. The British Journal of Cancer, 100(12), 1837 - 1841. https://doi.org/10.1038/sj.bjc.6605091

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is... Read More about Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review..

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? (2009)
Journal Article
Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?. The British Journal of Cancer, 100(12), 1837-1841. https://doi.org/10.1038/sj.bjc.6605091

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is... Read More about Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?.

Venous Thromboembolism in Advanced Disease: A clinical guide (2008)
Book
Lee, A. Y. Y., Johnson, M. J., & Noble, S. I. R. (Eds.). (2008). Venous Thromboembolism in Advanced Disease: A clinical guide. Oxford: Oxford University Press. https://doi.org/10.1093/acprof%3Aoso/9780199232048.001.0001

© Oxford University Press 2009. All rights reserved. There is increasing recognition of the burden of venous thromboembolism (VTE) in patients with advanced incurable disease and the clinical, ethical, and philosophical challenges they may pose. With... Read More about Venous Thromboembolism in Advanced Disease: A clinical guide.

Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis (2008)
Journal Article
Noble, S. I., Shelley, M. D., Coles, B., Williams, S. M., Wilcock, A., Johnson, M. J., & on behalf of Association for Palliative Medicine for Great Britain and Ireland. (2008). Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. The lancet oncology, 9(6), 577-584. https://doi.org/10.1016/s1470-2045%2808%2970149-9

Venous thromboembolism is common in patients with cancer. However, no management guidelines exist for venous thromboembolism specific to patients with advanced progressive cancer. To help develop recommendations for practice, we have done a comprehen... Read More about Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis.